vs
BALCHEM CORP(BCPC)与Orion Group Holdings Inc(ORN)财务数据对比。点击上方公司名可切换其他公司
BALCHEM CORP的季度营收约是Orion Group Holdings Inc的1.1倍($263.6M vs $233.2M),BALCHEM CORP净利率更高(14.9% vs -0.1%,领先15.0%),BALCHEM CORP同比增速更快(9.8% vs 7.5%),过去两年Orion Group Holdings Inc的营收复合增速更高(20.5% vs 4.9%)
Balchem Corp是一家全球特种化学品与营养原料供应商,核心业务覆盖人类营养、动物保健、制药、工业应用四大领域,为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
奥里昂集团是源自芬兰的全球化制药企业,1917年成立,总部位于芬兰埃斯波。公司面向全球市场研发、生产并销售人用与兽用药品以及药用活性成分,旗下全部生产基地与大部分研发部门均设立在芬兰。
BCPC vs ORN — 直观对比
营收规模更大
BCPC
是对方的1.1倍
$233.2M
营收增速更快
BCPC
高出2.3%
7.5%
净利率更高
BCPC
高出15.0%
-0.1%
两年增速更快
ORN
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $263.6M | $233.2M |
| 净利润 | $39.2M | $-240.0K |
| 毛利率 | 35.6% | 11.6% |
| 营业利润率 | 19.8% | 2.2% |
| 净利率 | 14.9% | -0.1% |
| 营收同比 | 9.8% | 7.5% |
| 净利润同比 | 16.8% | -103.6% |
| 每股收益(稀释后) | $1.21 | $-0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BCPC
ORN
| Q4 25 | $263.6M | $233.2M | ||
| Q3 25 | $267.6M | $225.1M | ||
| Q2 25 | $255.5M | $205.3M | ||
| Q1 25 | $250.5M | $188.7M | ||
| Q4 24 | $240.0M | $216.9M | ||
| Q3 24 | $239.9M | $226.7M | ||
| Q2 24 | $234.1M | $192.2M | ||
| Q1 24 | $239.7M | $160.7M |
净利润
BCPC
ORN
| Q4 25 | $39.2M | $-240.0K | ||
| Q3 25 | $40.3M | $3.3M | ||
| Q2 25 | $38.3M | $841.0K | ||
| Q1 25 | $37.1M | $-1.4M | ||
| Q4 24 | $33.6M | $6.8M | ||
| Q3 24 | $33.8M | $4.3M | ||
| Q2 24 | $32.1M | $-6.6M | ||
| Q1 24 | $29.0M | $-6.1M |
毛利率
BCPC
ORN
| Q4 25 | 35.6% | 11.6% | ||
| Q3 25 | 35.7% | 13.2% | ||
| Q2 25 | 36.4% | 12.6% | ||
| Q1 25 | 35.2% | 12.2% | ||
| Q4 24 | 36.0% | 14.0% | ||
| Q3 24 | 35.6% | 11.9% | ||
| Q2 24 | 35.5% | 9.5% | ||
| Q1 24 | 34.0% | 9.7% |
营业利润率
BCPC
ORN
| Q4 25 | 19.8% | 2.2% | ||
| Q3 25 | 20.4% | 2.4% | ||
| Q2 25 | 20.1% | 1.7% | ||
| Q1 25 | 20.4% | 0.4% | ||
| Q4 24 | 19.8% | 4.4% | ||
| Q3 24 | 20.0% | 3.4% | ||
| Q2 24 | 19.6% | -1.4% | ||
| Q1 24 | 17.4% | -1.9% |
净利率
BCPC
ORN
| Q4 25 | 14.9% | -0.1% | ||
| Q3 25 | 15.1% | 1.5% | ||
| Q2 25 | 15.0% | 0.4% | ||
| Q1 25 | 14.8% | -0.7% | ||
| Q4 24 | 14.0% | 3.1% | ||
| Q3 24 | 14.1% | 1.9% | ||
| Q2 24 | 13.7% | -3.4% | ||
| Q1 24 | 12.1% | -3.8% |
每股收益(稀释后)
BCPC
ORN
| Q4 25 | $1.21 | $-0.00 | ||
| Q3 25 | $1.24 | $0.08 | ||
| Q2 25 | $1.17 | $0.02 | ||
| Q1 25 | $1.13 | $-0.04 | ||
| Q4 24 | $1.03 | $0.22 | ||
| Q3 24 | $1.03 | $0.12 | ||
| Q2 24 | $0.98 | $-0.20 | ||
| Q1 24 | $0.89 | $-0.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $1.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.3B | $159.0M |
| 总资产 | $1.7B | $414.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
BCPC
ORN
| Q4 25 | $74.6M | $1.6M | ||
| Q3 25 | $65.1M | $4.9M | ||
| Q2 25 | $65.4M | $1.7M | ||
| Q1 25 | $49.9M | $13.0M | ||
| Q4 24 | $49.5M | $28.3M | ||
| Q3 24 | $73.7M | $28.3M | ||
| Q2 24 | $63.7M | $4.8M | ||
| Q1 24 | $60.3M | $4.6M |
总债务
BCPC
ORN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $33.4M | ||
| Q1 25 | — | $23.3M | ||
| Q4 24 | — | $23.2M | ||
| Q3 24 | — | $28.0M | ||
| Q2 24 | — | $60.3M | ||
| Q1 24 | — | $37.5M |
股东权益
BCPC
ORN
| Q4 25 | $1.3B | $159.0M | ||
| Q3 25 | $1.3B | $157.9M | ||
| Q2 25 | $1.3B | $153.2M | ||
| Q1 25 | $1.2B | $150.8M | ||
| Q4 24 | $1.1B | $150.7M | ||
| Q3 24 | $1.2B | $142.4M | ||
| Q2 24 | $1.1B | $111.1M | ||
| Q1 24 | $1.1B | $116.1M |
总资产
BCPC
ORN
| Q4 25 | $1.7B | $414.7M | ||
| Q3 25 | $1.7B | $422.4M | ||
| Q2 25 | $1.7B | $432.7M | ||
| Q1 25 | $1.6B | $416.3M | ||
| Q4 24 | $1.6B | $417.3M | ||
| Q3 24 | $1.6B | $430.3M | ||
| Q2 24 | $1.6B | $414.0M | ||
| Q1 24 | $1.6B | $363.6M |
负债/权益比
BCPC
ORN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.54× | ||
| Q1 24 | — | 0.32× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $67.3M | $13.8M |
| 自由现金流经营现金流 - 资本支出 | — | $454.0K |
| 自由现金流率自由现金流/营收 | — | 0.2% |
| 资本支出强度资本支出/营收 | — | 5.7% |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | — | $-10.8M |
8季度趋势,按日历期对齐
经营现金流
BCPC
ORN
| Q4 25 | $67.3M | $13.8M | ||
| Q3 25 | $65.6M | $23.3M | ||
| Q2 25 | $47.3M | $-5.6M | ||
| Q1 25 | $36.5M | $-3.4M | ||
| Q4 24 | $52.3M | $13.4M | ||
| Q3 24 | $51.3M | $37.5M | ||
| Q2 24 | $45.0M | $-15.3M | ||
| Q1 24 | $33.4M | $-22.8M |
自由现金流
BCPC
ORN
| Q4 25 | — | $454.0K | ||
| Q3 25 | — | $13.9M | ||
| Q2 25 | — | $-12.7M | ||
| Q1 25 | — | $-12.5M | ||
| Q4 24 | — | $9.9M | ||
| Q3 24 | — | $33.3M | ||
| Q2 24 | — | $-20.0M | ||
| Q1 24 | — | $-24.7M |
自由现金流率
BCPC
ORN
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 6.2% | ||
| Q2 25 | — | -6.2% | ||
| Q1 25 | — | -6.6% | ||
| Q4 24 | — | 4.6% | ||
| Q3 24 | — | 14.7% | ||
| Q2 24 | — | -10.4% | ||
| Q1 24 | — | -15.4% |
资本支出强度
BCPC
ORN
| Q4 25 | — | 5.7% | ||
| Q3 25 | — | 4.2% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | — | 2.4% | ||
| Q1 24 | — | 1.2% |
现金转化率
BCPC
ORN
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | 7.05× | ||
| Q2 25 | 1.23× | -6.61× | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | 1.98× | ||
| Q3 24 | 1.52× | 8.79× | ||
| Q2 24 | 1.40× | — | ||
| Q1 24 | 1.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
ORN
| Construction | $117.0M | 50% |
| Light Commercial | $85.8M | 37% |
| Dredging | $18.1M | 8% |
| Structural | $8.0M | 3% |
| Specialty Services | $4.3M | 2% |